INIT — Initiator Pharma A/S Cashflow Statement
0.000.00%
- SEK199.20m
- SEK160.35m
Annual cashflow statement for Initiator Pharma A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | DAS | DAS | DAS | — | DAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.5 | -24.2 | -44.1 | -27.7 | -14.5 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.291 | — | -0.536 | 0 | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.463 | -11.4 | 8.79 | 4.56 | -2.41 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.06 | -34.1 | -32.7 | -17.6 | -12.1 |
| Capital Expenditures | 0 | — | — | — | — |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 0 | -0.017 | 0 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | -0.017 | 0 | 0 |
| Financing Cash Flow Items | 0.414 | 0 | 0 | -0.001 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14 | 54.9 | 37.5 | 2.87 | 1.11 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.94 | 20.8 | 4.77 | -14.8 | -11 |